Definium Therapeutics, Inc. (DFTX) stock
DFTXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$32.08−0.92 (-2.79%)
Close on Nov 13, 2026Market cap $4.31BP/E –Yield –
Definium Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Definium Therapeutics's total assets was $1.07B at Sep 30, 2026. For fiscal 2025 it was $440.10M, up 45.7% from the year before. The highest annual figure on record is $440.10M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $440.10M | +45.7% |
| FY2024 | Dec 31, 2024 | $302.15M | +142.6% |
| FY2023 | Dec 31, 2023 | $124.54M | -26.7% |
| FY2022 | Dec 31, 2022 | $169.99M | +3.7% |
| FY2021 | Dec 31, 2021 | $164.00M | +101.2% |
| FY2020 | Dec 31, 2020 | $81.52M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.07B | +353.4% |
| Q2 FY2026 | Jun 30, 2026 | $1.11B | +319.8% |
| Q1 FY2026 | Mar 31, 2026 | $401.29M | +45.8% |
| Q4 FY2025 | Dec 31, 2025 | $440.10M | +45.7% |
| Q3 FY2025 | Sep 30, 2025 | $236.92M | -25.9% |
| Q2 FY2025 | Jun 30, 2025 | $265.09M | -1.1% |
| Q1 FY2025 | Mar 31, 2025 | $275.32M | -0.1% |
| Q4 FY2024 | Dec 31, 2024 | $302.15M | +142.6% |
| Q3 FY2024 | Sep 30, 2024 | $319.77M | +125.9% |
| Q2 FY2024 | Jun 30, 2024 | $268.15M | +88.7% |
| Q1 FY2024 | Mar 31, 2024 | $275.53M | +77.2% |
| Q4 FY2023 | Dec 31, 2023 | $124.54M | -26.7% |
| Q3 FY2023 | Sep 30, 2023 | $141.55M | -21.8% |
| Q2 FY2023 | Jun 30, 2023 | $142.09M | +5.8% |
| Q1 FY2023 | Mar 31, 2023 | $155.53M | +4.2% |
| Q4 FY2022 | Dec 31, 2022 | $169.99M | +3.7% |
| Q3 FY2022 | Sep 30, 2022 | $180.91M | +121.9% |
| Q2 FY2022 | Jun 30, 2022 | $134.28M | – |
| Q1 FY2022 | Mar 31, 2022 | $149.23M | – |
| Q4 FY2021 | Dec 31, 2021 | $164.00M | – |
| Q4 FY2020 | Dec 31, 2020 | $81.52M | – |
See a number that looks wrong?